Report Store Get Proposal

Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Home Blog Oncology 39

Oncology

medtech-news-for-insulet-bd-medtronic-artivion-omnysense

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Insulet’s Omnipod 5 Automated Insulin Delivery System; Alivecor’s KardiaMobile Card; BD Board Approved the Spinoff of embecta; Medtronic’s Hugo Surgery Robot; Artivion’s On-X® Mitral Heart Valve PROACT; OmnySense’s Smart Thermometer Clinical Trial

Insulet Received FDA Clearance for its Omnipod® 5 Automated Insulin Delivery System, First Tubeless System with Smartphone Control On January 28, 2022, Insulet Corporation, a market leader in developing tubeless insulin pumps with its product, Omnipod®, received the FDA approval for its Omnipod® 5 Automated Insulin Delivery System (Omnipod 5). The system is designed for individuals aged six-year and above with type 1 diabetes. It is the first tubeless automated insulin delivery system that is compatible with smartphones and combines with the Dexcom G6 Continuous Glucose Monitoring (CGM) System to automatically adjust insulin and help protect against highs and lows....

Explore More...

Johnson & Johnson

Epic Sciences garners; Tvardi gets financing; Galera raises; Fund for cancer research

Novo Nordisk

Snippet

biosimilar

Biologic Parallel – A Perky Future Ahead

transthyretin amyloidosis

Notizia

Pancreatic Cancer

Pancreatic Cancer Treatment to Stride Beyond Chemotherapy

Johnson & Johnson

Atreca secured $125M; OncoResponse bags $40M; Kodiak Sciences’s IPO; Biodesy contemplates $20M

Migraine

Snippet

transthyretin amyloidosis

Notizia

Nanoparticles

Now, Nanoparticles for Cancer Treatment

Johnson & Johnson

4D Molecular Therapeutics raises; Arvinas slates for IPO; Sutro ruminates for $ 75M; Emergent BioSolutions remunerates Narcan maker

astellas

Commercial

cancer

Clinical

FDA

AbbVie Receives Approval; Kymriah Approved; Shire Gets USFDA Approval; NICE Rejects; Bristol-Myers Squibb’s Opdivo; Eisai and Merck Get USFDA Approval

Default Blog Image

Outset Medical captures; Wright Medical Group to takeover Cartiva; Y-mAbs Therapeutics prepares for IPO; Biotech boom remunerates analysts

Novo Nordisk

China Preparing for Pharma Big Bang: Is this Alarm Bell for US, Euro Pharma Giants?

HCC

Japan Manages to Stand Apart from Global Hepato Cellular Carcinoma Crowd

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly